No Detail Found!

Effect of iron chelator on renal function in thalassemia patients who undergo regular transfusion

Author(s)
HALIMA SADIA Bacha Khan Medical College,Mardan, Pakistan
FURQAN ALI SHAH Pak International medical college,Peshawar, Pakistan
REHANA RASOOL Abbottabad International Medical College Abbottabad, Pakistan
AMTUL Hafeez Islam Medical College,Sialkot, Pakistan
AYESHA IFTIKHAR Sardar Begum Dental College,Peshawar, Pakistan
HAFIZ SAJID AKBAR Bacha Khan Medical College,Mardan, Paksitan
ALIA NASEER University of Lahore,Lahore, Pakistan
SUDHAIR ABBAS BANGASH Sarhad University of Science and Information Technology,Peshawar, Pakistan
Abstract
Background: The thalassemia family of genetic disorders is characterized by an abnormal synthesis of the hemoglobin chain, resulting in chronic anemia in some people and clinically asymptomatic in others. There have been very few studies conducted on the effects of thalassemia on the kidneys, which typically included patients treated with deferoxamine having both glomerular and tubular dysfunction. Objective: This research aimed to determine whether kidney dysfunction is observed in young thalassemic individuals manipulating both conventional and primitive markers of kidney dysfunction, and to associate the results to the use of iron chelation therapy. Methods: We measured serum cystatin C (Cys C), tubular phosphorus reabsorption (TPRA), fractional sodium excretion (FNE), and 2-microglobulin, urine calcium, protein, and glucose levels in addition to the usual renal biochemistry. Results: A whole of 42 individuals, ranging in age from 4 to 23, were included in this study and were split into two groups for study (group A taking deferoxamine alone, and group B taking deferiprone coupled with deferoxamine). An increased Cys C level (36%) and proteinuria (24%) were seen in a large percentage of patients, as were tubulopathy with hypercalciuria (35.5 %) and point out 2-MG excretion (33.5 %). Conclusion: Patients with -thalassemia seem to suffer from renal dysfunction even when they are young, so it is important to monitor early signs of renal dysfunction. There is a need for further research into the effect of novel chelators on parameters tubular function.
Publication Details
Page(s) 1403-1405
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 1, Year: 2022

Request the full text from PASTIC

Keywords
Peshawar, Thalassemia, dfo, iron chelator, Deferiporin
0

Citations

0

Downloads

36

Views